A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

摘要: Background: The hepatitis C pandemic has been systematically studied and characterized in North America Europe, but this important public health problem not received equivalent attention other regions. Aim: objective of systematic review was to characterize virus (HCV) epidemiology selected countries Asia, Australia Egypt, i.e. a geographical area inhabited by over 40% the global population. Methodology: Data references were identified through indexed journals non-indexed sources. In work, 7770 articles reviewed 690 based on their relevance. Results: We estimated that 49.3‐64.0 million adults Egypt are anti-HCV positive. China alone more HCV infections than all Europe or Americas. While most had prevalence rates from 1 2% we documented several with relatively high rates, including (15%), Pakistan (4.7%) Taiwan (4.4%). Nosocomial infection, blood transfusion (before screening) injection drug use as common risk factors region. Genotype Australia, China, while genotype 6 found Vietnam Southeast Asian countries. India 3 predominant, 4w Middle Eastern such Saudi Arabia Syria. Conclusion: recommend implementation surveillance systems guide effective policy may lead eventual curtailment spread infection.